SCHEDULE: Neuronetics Shareholder Jorey Chernett Updates Ownership Filing

Jorey Chernett has updated their Schedule 13D filing for Neuronetics, Inc. to reflect a current ownership of approximately 13.92% following a change in the total number of outstanding shares.

Summary

• Jorey Chernett, a significant shareholder in Neuronetics, Inc., has filed an amendment (Amendment No. 4) to their Schedule 13D.
• This filing primarily updates the reporting person's ownership percentage to 13.92%, based on 76,197,222 shares outstanding as of August 5, 2026.
• The previous filing was amended to reflect changes in the Issuer's outstanding shares as reported in Neuronetics' Form 10-Q filed on August 11, 2026.
• Chernett beneficially owns 10,602,988 shares, with sole voting and dispositive power over these shares.
• The total aggregate purchase price for these shares was approximately $20,726,476, acquired using personal funds.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, primarily reflecting an update to ownership percentages due to a change in outstanding shares rather than significant new activity.

Positives

• The filing confirms Jorey Chernett's continued significant stake in Neuronetics, Inc. at 13.92%.
• The update reflects a transparent adjustment to ownership based on publicly reported changes in outstanding shares, indicating adherence to disclosure requirements.

Negatives

• No new negative information or significant changes in strategy or financial performance are indicated by this specific filing.

Risks

• The filing does not introduce new risks but is subject to the general risks associated with investing in a publicly traded company, including market volatility and company-specific operational risks.

Future Outlook

This filing is an update to reflect current ownership based on outstanding shares and does not contain specific forward-looking statements or guidance from management regarding future business operations or financial performance.

Industry Context

StockSavvy.ai notes that Schedule 13D filings are routine for significant investors and are often updated to reflect changes in share counts or ownership adjustments. This filing for Neuronetics, Inc. appears to be a standard procedural update rather than an indication of a new investment strategy or a change in the company's fundamental outlook.

Stakeholder Impact

• Shareholders: The filing provides transparency on a major shareholder's stake, reinforcing confidence in disclosure practices. It does not directly alter existing share value but confirms a substantial holder's position.

Next Steps

• Continue to monitor Neuronetics, Inc.'s filings for any further changes in beneficial ownership or strategic disclosures.

Key Dates

Keywords

Neuronetics, Schedule 13D, Ownership Update, Beneficial Ownership, Common Stock, SEC Filing, Shareholder